Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
NCT00179426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2017-03-13
Summary
The purpose of this study is to determine if antiseizure drugs affect hormone levels and sexual function in men with seizures.
Conditions
- Seizure Disorder
- Epilepsy
Sponsors & Collaborators
- collaborator INDUSTRY
-
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Andrew G. Herzog, M.D., M.Sc. · Beth Israel Deaconess Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-10-31
- Completion
- 2006-06-30
Countries
- United States
Study Locations
More Related Trials
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED
-
Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
NCT00204074 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
NCT00808132 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
NCT00236301 ·Status: TERMINATED ·Phase: PHASE3
-
Aging and Estrogen on Cortical Function
NCT01268046 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
NCT06191289 ·Status: TERMINATED ·Phase: PHASE2
-
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
NCT02122198 ·Status: COMPLETED ·Phase: NA
-
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
NCT00060736 ·Status: COMPLETED
-
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
NCT04841499 ·Status: COMPLETED ·Phase: NA
-
Low-dose Hormone Therapy for Relief of Vasomotor Symptoms
NCT00446199 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Gynodian® Depot in Women With Impaired Well-being
NCT00463450 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen and Diabetes
NCT03436992 ·Status: COMPLETED ·Phase: NA
-
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
NCT03018366 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
NCT00004274 ·Status: COMPLETED ·Phase: NA
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Hormonal Imbalance
NCT05328609 ·Status: COMPLETED ·Phase: NA
-
Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms
NCT06787443 ·Status: COMPLETED ·Phase: NA
-
Alzheimer's Disease Prevention Trial
NCT00000176 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women
NCT00675688 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women
NCT00005768 ·Status: UNKNOWN ·Phase: PHASE2
-
One Week Clinical Study in Subjects With Menopausal Symptoms
NCT06794021 ·Status: COMPLETED ·Phase: NA
-
Estrogen Hormone Products
NCT05645406 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy
NCT01986764 ·Status: WITHDRAWN ·Phase: NA
-
Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
NCT00012909 ·Status: COMPLETED ·Phase: NA